Purchase Order HT941024P0100
Award Date
7/25/24
Potential Completion Date
9/30/24
Potential Value
$46K
Federal Agency
Defense Health Agency
Awardee
Cell Marque Corp
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Rocklin, CA 95677, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $32,200 firm fixed-price purchase order contract awarded by the Defense Health Agency to Cell Marque Corporation, a small business manufacturer of antibodies and reagents for in vitro diagnostic use. The contract is a total small business set-aside and involves delivering specialized antibodies for use with Ventana BenchMark autostainers and other advanced medical diagnostic equipment to support patient care and diagnostic testing at naval and military medical facilities. The...
This federal contract award was made by the Defense Health Agency (DHA) to Cell Marque Corp, a for-profit manufacturer of antibodies and reagents for in vitro diagnostic use. The $74,453.00 firm fixed-price contract, issued as a Blanket Purchase Agreement (BPA) call, is for the delivery of specialized laboratory reagents, antibodies, and diagnostic supplies to support medical facilities including Naval Medical Center San Diego and Walter Reed Medical Center. The contract has an ultimate...
This federal contract award is for the delivery of reagents to the Defense Health Agency (DHA), a defense agency. The prime contractor is Cell Marque Corp, a for-profit organization and manufacturer of antibodies and reagents for immunohistochemistry. The contract is a Blanket Purchase Agreement (BPA) call with a firm fixed price, with a ceiling value of $135,000.00 and a period of performance through September 30, 2016. This award is not a set-aside. Cell Marque has previously provided a...
This firm fixed price blanket purchase agreement (BPA) call contract was awarded by the Defense Health Agency to Cell Marque Corporation on November 6, 2019 for the delivery of antibodies and kits for the agency's Pathology Department. With a potential value of $78,882.58, the contract has a completion date of November 5, 2020 and does not have a set-aside designation. Cell Marque Corporation will deliver the requested products from their facility located in Bethesda, Maryland to support the...
This federal contract award, valued at $55,168.14, was issued by the Defense Health Agency (DHA) to Cell Marque Corporation, a manufacturer and supplier of antibodies and reagents for immunohistochemistry. The award is a firm fixed-price Blanket Purchase Agreement (BPA) call for the delivery of various reagents and peripheral consumables, such as the Marque Corp BOB 1 and CD1a antibody reagents. This BPA contract, with a total potential value of $650,000, serves as an indefinite delivery vehicle...
<p>Cell Marque Corporation was awarded a $100,000 firm fixed price blanket purchase agreement (BPA) call contract by the Defense Health Agency to provide reagents and supplies. The contract has a period of performance through November 2021 for products to be delivered to locations in Bethesda, Maryland. No set-aside provisions were applied to this award made by the agency to support its medical research and healthcare programs.</p>
The Defense Health Agency Contracting Activity (DHACA) has awarded a sole source supply contract to Roche Diagnostics Corporation for the lease of tissue staining equipment and related consumables for the Histology Division at the Naval Medical Center San Diego (NMCSD). The contract is a firm fixed price purchase order with a ceiling value of $2,111,013.00 and a period of performance from July 1, 2024 to June 30, 2029. The contract includes the lease of two tissue antibody detection...
The U.S. Department of the Navy Bureau of Medicine and Surgery awarded a $131,758.96 firm-fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The award is for numerous antibodies in various quantities for the Ventana Benchmark System used in NMCSD laboratories. This award does not have a set-aside designation and was made on a sole-source basis due to only one source being able to meet...
<p>This is a firm fixed-price delivery order awarded by the Bureau of Medicine and Surgery, a component of the U.S. Navy, to Ventana Medical Systems, Inc. for $148,516.61. The contract is for the Naval Medical Center San Diego's lab department requirement for detection kits and antibodies for slide stainers. The contract has no set-aside designation and has an ultimate completion date of August 27, 2016. Ventana Medical Systems, Inc. is a for-profit, foreign-owned manufacturer of goods.</p>
This is a delivery order contract awarded by the Bureau of Medicine and Surgery, a defense agency, to Ventana Medical Systems, Inc., a for-profit manufacturer, for the supply of antibodies for slide stainers. The contract has a ceiling value of $39,844.34 and was awarded on August 2, 2016, with a completion date of December 2, 2018. The contract does not have a set-aside designation. This delivery order is likely part of a larger contract vehicle used by the agency to procure medical supplies...